Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn Validation ...

In support of this annual event, Spectral AI will host a series of internal activities to engage employees, including inspiring messages from leadership, personal stories from biomedical engineers ...

Spectral AI, a Dallas-based company specializing in predictive AI for medical diagnostics, has announced the installation of three DeepView® System devices in Australia, following the Australian ...

DALLAS, May 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging ...

Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...

DALLAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (Spectral AI or the Company), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable ...

DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...

DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...

Spectral AI, Inc. (NASDAQ:MDAI) is one of the most popular AI penny stocks to buy according to billionaires. On June 30, Spectral AI (NASDAQ:MDAI) submitted a De Novo 510k application to the FDA for ...